FDA To Review Children's Cough And Cold Medicines

The US Food and Drug Administration (FDA) has announced it is calling a meeting of its Nonprescription Drugs Advisory Committee next month to review the safety and effectiveness of medicines used to treat coughs and colds in children following recent concerns about their use, especially in infants below two years of age. Part of the review will cover reports of medical problems arising from incorrect use of cough and cold drugs for children, especially overdoses. For example, in some cases parents have not realized that different products may contain the same active ingredient and giving a child both at the same time results in a combined dosage that exceeds the safety level